Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.
Ayşenur Paç KısaarslanBetül SözeriZubeyde GunduzGökmen ZararsızHakan PoyrazoğluRuhan DüşünselPublished in: European journal of rheumatology (2019)
In our study, the absence of factors affecting the duration of DMARDs application in patients with ERA showed that DMARDs may still be applied as the first line of treatment.